Clinical predictors of efficacy for immune checkpoint inhibition in lung cancer patients.

Shijia Zhang,Daniel Fellows Pease,Shilvi Joshi,Yucai Wang,Manish R. Patel

Clinical predictors of efficacy for immune checkpoint inhibition in lung cancer patients.

2019

Shijia Zhang
Daniel Fellows Pease
Shilvi Joshi
Yucai Wang
Manish R. Patel

e20600Background: Immune checkpoint inhibitors (ICIs) have changed the treatment paradigm of advanced NSCLC and SCLC. The populations in clinical trials generally were composed of patients (pts) wi...

Keywords:

Oncology
Lung cancer
Immune checkpoint
Pathology
Internal medicine
Medicine
Clinical trial
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations